Alzinova AB (ALZ) - Total Liabilities

Latest as of March 2026: Skr9.91 Million SEK ≈ $1.07 Million USD

Based on the latest financial reports, Alzinova AB (ALZ) has total liabilities worth Skr9.91 Million SEK (≈ $1.07 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Alzinova AB (ALZ) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Alzinova AB - Total Liabilities Trend (2012–2025)

This chart illustrates how Alzinova AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ALZ total asset value.

Alzinova AB Competitors by Total Liabilities

The table below lists competitors of Alzinova AB ranked by their total liabilities.

Company	Country	Total Liabilities
Wise Group AB ST:WISE	Sweden	Skr132.58 Million
Palamina Corp V:PA	Canada	CA$695.24K
Moonpig Group PLC LSE:MOON	UK	GBX238.69 Million
LBI Capital Bhd KLSE:8494	Malaysia	RM52.70 Million
Green Packet Bhd KLSE:0082	Malaysia	RM130.66 Million
Reliance Chemotex Industries Limited NSE:RELCHEMQ	India	Rs-1.43 Billion
Nexted Group Ltd AU:NXD	Australia	AU$97.66 Million
TFP Solutions Bhd KLSE:0145	Malaysia	RM6.57 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Alzinova AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ALZ equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alzinova AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alzinova AB (2012–2025)

The table below shows the annual total liabilities of Alzinova AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr21.47 Million ≈ $2.31 Million	+128.33%
2024-12-31	Skr9.40 Million ≈ $1.01 Million	+0.77%
2023-12-31	Skr9.33 Million ≈ $1.00 Million	+53.27%
2022-12-31	Skr6.09 Million ≈ $655.15K	+89.09%
2021-12-31	Skr3.22 Million ≈ $346.48K	-32.81%
2020-12-31	Skr4.79 Million ≈ $515.68K	+8.40%
2019-12-31	Skr4.42 Million ≈ $475.71K	+89.33%
2018-12-31	Skr2.33 Million ≈ $251.26K	+0.26%
2017-12-31	Skr2.33 Million ≈ $250.60K	+64.85%
2016-12-31	Skr1.41 Million ≈ $152.02K	-9.79%
2015-12-31	Skr1.57 Million ≈ $168.51K	+165.74%
2014-12-31	Skr589.25K ≈ $63.41K	-19.06%
2013-12-31	Skr728.02K ≈ $78.35K	+328.80%
2012-12-31	Skr169.78K ≈ $18.27K	--

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$9.77 Million

Skr90.78 Million SEK

Market Cap Rank

#27219 Global

#589 in Sweden

Share Price

Skr0.45

Change (1 day)

+7.31%

52-Week Range

Skr0.40 - Skr2.03

All Time High

Skr26.90